eGenesis News and Activities

Acquisition, funding and merger involving eGenesis.

• eGenesis has just announced a $191 Million fundraising (posted on September 6 2024).

View the org chart displaying its 35 main executives

Most searched biographies at eGenesis

• Michael Curtis, President and Chief Executive Officer
• Lucio Iannone, Director
• Al Wiegman, Director

Popular executive movements at eGenesis

• Glenn Vraniak has joined the company as Chief Financial Officer  (posted on June 22 2026).
• Jennifer Bergheiser, who was Chief Business Officer, is promoted to Chief Commercial Officer  (posted on June 22 2026).

Create your alert
to follow the executive moves at eGenesis.

eGenesis has 2,423 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).
• BridgeBio has just announced a $1,000 Million fundraising (posted on July 2 2026).
• Flare Therapeutics has just announced a $85 Million fundraising (posted on July 2 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by eGenesis

• Press Coverage | eGenesis Bio
• Press Releases | eGenesis Bio

Social media about eGenesis

• eGenesis on Wikipedia, Google News & Yahoo Finance
• eGenesis on LinkedIn, X (Twitter) & YouTube